Table 2.
Clinical characteristics of AAA patients and controls in validation stage.
| Characteristics | AAA (n = 11) | Controls (n = 12) | P value |
|---|---|---|---|
| Age (years) | 60.64 ± 10.51 | 52.83 ± 8.97 | 0.081 |
| Gender (male) | 11 (10) | 12 (9) | 0.315 |
| BMI | 24.19 ± 3.71 | 25.88 ± 4.17 | 0.275 |
| Smoking habit | 11 (5) | 12 (2) | 0.855 |
| Comorbidities | 0.165 | ||
| Hypertension | 9 | 3 | |
| Diabetes mellitus | 2 | 1 | |
| Dyslipidemia | 0 | 1 | |
| CAD | 2 | 5 | |
| COPD | 0 | 1 | |
| SBP (mmHg) | 143.73 ± 15.64 | 133.33 ± 11.17 | 0.079 |
| DBP (mmHg) | 90.36 ± 14.62 | 74.75 ± 7.24 | 0.003 |
P < 0.05 showed difference was statistically significant between the AAA and control groups. BMI: Body mass index; CAD: Coronary artery disease; COPD: Chronic obstructive pulmonary disease; SBP: Systolic blood pressure; DBP: Diastolic blood pressure.